PsyFi

In this episode of PsyFi, we sit down with Dr Stuart Seidman, a clinical psychologist treating patients on the severe end of mental health disorders. He believes psychedelic medicines are a game-changer for the field of psychology.

PsyFi - Unraveling the Mysteries of Psychedelic Science

WATCH the live recording: https://youtu.be/nataU-PaWuI

Stuart Seidman | Partner, Negev Capital

Stuart Seidman has a medical practice in psychopharmacology in New York City, owns an outpatient psychiatry clinic on the Upper West Side, and teaches psychiatry at the Chaim Sheba Medical Center in Israel. He went to medical school at Emory University, did a medical internship at the University of Pennsylvania, and was trained in epidemiology for 2 years at the Centers for Disease Control. He then completed a residency in psychiatry and a fellowship in psychopharmacology at Columbia University. He remained at Columbia as an attending physician for 15 years, during which his research focus was on the role of androgens in CNS function. He has been principal investigator of numerous clinical trials concerning exogenous testosterone and mood.

Negev Capital

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP. We believe that psychedelic medications will be not only disruptive to the practice of psychiatry, but hold the potential to reduce enormous amounts of human suffering, and we are committed to helping the field mature, and further promote ways for these treatments to reach all of those in need.

Robin Arnott, CEO of Andromeda Entertainment, talks about life experiences that ultimately led him to creating a unique immersive gaming-and-music art-meets-science offering in the psychedelic space.

Robin Arnott, CEO, Andromeda Entertainment, is a game designer and longstanding public speaker in the industry of consciousness technology. He was featured in Netflix’s Screenland and the documentary Game Loading: Rise of the Indies. As the lead developer of SoundSelf: A Technodelic, Robin is an expert in the means by which technology can profoundly impact player consciousness.

Video on Youtube: https://youtu.be/EecpyiNF4FY

Subscribe today!

PSY FIUNRAVELING THE MYSTERIES OF PSYCHEDELIC SCIENCEWe take an evidence-based exploration into the world of psychedelic medicine with leading researchers, clinicians and industry experts.

Dr. Steven MandelFounder and President, Ketamine Clinics Los Angeles

Dr. Steven Mandel is an internationally-recognized expert and pioneer in the use of ketamine infusion therapy to treat mental health disorders and chronic pain. Dr. Mandel has more than 40 years of experience utilizing ketamine as a board-certified anesthesiologist. He also earned his master’s degree in psychology. He is the founder and president of Ketamine Clinics Los Angeles, a leading ketamine infusion therapy clinic in Southern California. Dr. Mandel is also founder and first president of ASKP.

Sam MandelCofounder and Chief Operating Officer, Ketamine Clinics Los Angeles

Sam Mandel is a lifelong mental health advocate and entrepreneur. Mandel started Ketamine Clinics Los Angeles with his father, Dr. Steven Mandel, in 2014 and has grown the clinic to be one of the most successful and well-respected ketamine infusion therapy clinics in the US. Mandel is responsible for the day-to-day operations of KCLA and manages its staff of 10. He oversees all non-clinical functions, including patient satisfaction, vendors, marketing, technology, development, and finance.

LINKS:https://ketamineclinics.com/ (https://ketamineclinics.com/)

TIMESTAMPS:1:18: Ketamine is not new — supported War Vets in the 70s.

6:35 Among the first Physicians to apply Ketamine with patients.

6:53 In 2014 Many people considered it very experimental.

8:04 3 Different populations of patients.

9:10 Mental health benefits of Ketamine at anesthetic doses.

12:14 Spearheading the movement of using chemicals to promote better mental health.

15:10 Why is Ketamine so effective, so quickly?

17:05 Ketamine works on chemical level and experiential level.

23:50 Evidence-based approach.

28:42 Ketamine vs. Traditional treatment efficacy.

32:30 Ketamine is no longer a last resort.

34:49 Ketamine has no long-term side effects. Quality of Relief.

39:23 Ketamine is an activator rather than a depressant.

42:52 Working with my son.

45:05 Working with my father.

50:37 What about the 17% who don't experience benefits?

55:15 Is Ketamine frequently abused or addictive?

59:44 The largest cause of disability globally? Depression.

1:03:45 Ketamine is the fastest acting, safest, most effective anti-depressant.

1:04:34 Ketamine saves lives.

Video on Youtube: https://youtu.be/XF4Zps6dOVA

Noah CraftCofounder and Co-CEO, People Sciencehttps://peoplescience.health/ (https://peoplescience.health/)

Noah is a physician-scientist-entrepreneur. He is the Co-Founder/Co-CEO of People Science, focused on self-inquiry and the RandD of alternative medicines. He was previously the co-founder/CEO of Science 37, one the industry leaders in Virtual Clinical Trials. Before that, he ran a successful translational research laboratory at LA Biomed and serves as a strategic advisor to multiple biotech companies including Bexson Biomedical. He lives with his wife, son, and 2 dogs in Venice Beach, California.

Belinda TanCo-founder and Co-CEO, People Sciencehttps://peoplescience.health/ (https://peoplescience.health/)

Belinda Tan MD, PhD, is a physician-scientist-entrepreneur who spent her formative professional training years in Los Angeles where she currently resides. Early in her career, she began applying high impact technology ideas to clinical practice with the purpose of providing broader access to quality care. She is Co-Founder and Co-CEO of People Science, a clinical research marketplace for the RandD of alternative medicines. Dr. Tan is in the early founding team and continuing advisor to DirectDerm, the national leader delivering teledermatology services and improving health outcomes among underserved populations. She previously co-founded and served as Chief Medical Officer of Science 37, a venture-backed pioneering market leader in virtual clinical trials that led several groundbreaking first-ever FDA-regulated studies. The company’s focus on bringing clinical research to people in their homes significantly improved diversity among clinical study participants, from an average of 5% to 40%. Dr. Tan is a continuing student of life, a listener, and a mentor. As a wife, mother, daughter, and sister, her first-generation American journey has enriched her appreciation of belonging to a global citizenship and of cultural competence as a healthcare provider and entrepreneur. Her personal and professional pursuits are guided by promoting inclusivity, attribution, and access. Inspired by the needs of people seeking healthcare within the LA County public health system where she trained, Dr. Tan continues to mentor medical students and residents as Assistant Clinical Professor of Medicine at Harbor-UCLA Medical Center. Her board and advisory roles involve the Los Angeles Mayor’s WiSTEM (Women in STEM) Initiative, 826LA, Bexson Biomedical, Seed Health, and VisualDx. She earned her MD and PhD from UCLA and BS from MIT, with additional clinical training at the Memorial Sloan-Kettering Cancer Center and Cornell-New York Presbyterian Hospital. She lives with her husband, son, and two Labradors in Venice Beach.

Reid Robison, MD, MBANovamind VenturesChief Medical Officer and DirectorDr. Reid Robison is a board-certified psychiatrist who was named Best Psychiatrist in Utah by Salt Lake City Weekly’s Best of Utah Body and Mind 2020. Dr. Robison is the co-founder of Cedar Psychiatry and serves as the Medical Director for the Center for Change, a leading Eating Disorder center. He is currently the coordinating investigator for the MAPS-sponsored MDMA-assisted psychotherapy study of eating disorders. As an early adopter and researcher of ketamine in psychiatry, Dr. Robison led a pivotal IV ketamine study for treatment-resistant depression by Janssen, leading up to the company’s recent FDA-approval of Spravato™. To date, Dr. Robison has guided thousands of ketamine therapy journeys and hundreds of Spravato™ dosing sessions. As a social entrepreneur, Dr. Robison has built a number of purpose-driven companies including Tute Genomics which was acquired by PierianDx in 2016. Dr. Robison is also an adjunct professor at both the University of Utah and Brigham Young University and is the founder of the Polizzi Free Clinic, a free mental health clinic for marginalized people based in Salt Lake City, Utah.

Erica ZelfandSimba HealthPhysicianDr. Erica Zelfand is a licensed family physician specializing in integrative and functional medicine. She is also a facilitator of therapeutic psychedelic experiences, and teaches professional trainings on the medicinal use of these powerful substances.

www.ericazelfand.com

www.microdose.buzz/psychedelic-guides-with-dr-erica-zelfand

David RosenSecret Chord LaboratoriesCo-founder and CEODavid Rosen, PhD has published interdisciplinary research in an array of domains: creative cognition, music perception, music production, verbal creativity, education, and engineering. His most recent work (publications under review) investigates the role of psychedelics in psychological well-being and social judgments. He is a skilled presenter, having been invited to speak at domestic and international conferences, events, and podcasts. His leadership positions in research labs, classrooms, and the music industry guides his leadership and management strategy. David has been playing the piano since age eight, composing since age 16 and has formal jazz training on the electric bass.

www.secretchordlaboratories.com

Trey BrasherUnlimited SciencesResearcherTrey Brasher is a pharmacology researcher from Denver, Colorado. He has previously conducted research at Stockton University and Rutgers University in New Jersey. He is currently working with Unlimited Sciences, a psychedelic research startup based out of Denver, on several studies including a real-world psilocybin study sponsored by Johns Hopkins.

www.unlimitedsciences.org

Lucia HuangOsmindCo-founder and CEOLucia previously worked to help find cures for ALS and Parkinson’s at Verge Genomics, an AI-driven neuroscience biotech startup. At Verge, she helped scale the company from seed to post-Series A. She previously invested in innovative healthcare technology companies at Warburg Pincus. Lucia started her career advising pharmaceutical companies in investment banking. Lucia graduated Yale with a B.S. in Chemistry and earned an MBA at Stanford Graduate School of Business, where she was also awarded a Certificate in Public Management and Social Innovation. At Stanford, Lucia focused her studies on healthcare and co-led the GSB Healthcare Club. Lucia is passionate about mental health and has devoted her career to improving healthcare, from life sciences to new technology innovation.

www.osmind.org

Dr. Marvin S. Hausman, MDNova Mentis Life Science Corp., Pilz BioscienceChairman of Nova Mentis' Scientific Advisory Board; Board Chairman and Chief Scientific Officer for Pilz BioscienceDr. Marvin S. Hausman is the Chief Medical Officer of Pilz Bioscience Corp., a wholly-owned subsidiary of Nova Mentis, and is leading their research and development efforts in medicinal psychedelics. Dr. Hausman is also Chairman of Nova Mentis' Scientific Advisory Board. Dr. Hausman is an immunologist and board-certified urological surgeon with more than 30 years of drug research and development experience with various pharmaceutical companies, including Bristol-Myers International, Mead-Johnson Pharmaceutical Co., E.R. Squibb, Medco Research and Axonyx.

Youtube link: https://youtu.be/bOaGQHvM7sQ (https://youtu.be/bOaGQHvM7sQ)

Jillian HagelMagicMed Industries Inc.Chief Technology Officer (CTO)Dr. Jillian Hagel is the Chief Technology Officer for MagicMed Industries Inc. Jill leads the science team in delivering milestones and science program coordination. Dr. Hagel has over 19 years’ experience in plant biochemistry and natural products biosynthesis. Before co-founding MagicMed Industries, Dr. Hagel held the position of Vice President, Applied Science and co-founder of Willow Biosciences Inc. (TSX: WLLW). Dr. Hagel was COO of Epimeron Inc. before the acquisition of Epimeron by Willow. Dr. Hagel has coauthored over 35 peer-reviewed publications and is the co-inventor on many patent applications. Dr. Jillian Hagel received her Ph.D. in natural products biochemistry in 2010 from the University of Calgary.